Retatrutide is a multi-receptor peptide agonist targeting GLP-1, GIP, and glucagon receptors, representing a next-generation approach in metabolic research. It is studied for its interaction with complex hormonal signaling pathways involved in glucose metabolism, energy expenditure, and appetite regulation. Research models examine its effects on insulin response, glucagon activity, and thermogenic processes through triple-receptor engagement. Its design allows for comprehensive modulation of metabolic pathways in controlled experimental conditions. Additional investigations focus on receptor binding behavior and downstream signaling integration across endocrine systems. Ongoing studies continue to explore its pharmacokinetics and biochemical interactions.